Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Oral Investig ; 25(5): 3043-3057, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33104929

RESUMO

OBJECTIVES: The aim of this study was to investigate if bone regeneration can be promoted by homologous transplantation of STRO-1 sorted (STRO-1+) porcine tooth germ mesenchymal stem cells (TGSCs) with the combination of polyethylenglycol (PEG)-based hydrogel and biphasic calcium phosphate (BCP) scaffolds. MATERIAL AND METHODS: TGSCs were isolated from impacted third molars of domestic pigs. Nine critical-sized defects were created as (1) untreated defect; filled with (2) autogenous bone; (3) BCP + PEG; (4) BCP + PEG + unsorted TGSCs; (5) BCP + unsorted TGSCs; (6) BCP + PEG + STRO-1-sorted TGSCs; (7) BCP + STRO-1-sorted TGSCs; (8) BCP + PEG + osteogenic induced unsorted TGSCs; and (9) BCP + PEG + osteogenic induced STRO-1-sorted TGSCs in 20 domestic pigs. CM-DiI labelling was used to track cells in vivo. Histomorphometric assessment of new bone formation was achieved by toluidine blue O staining and microradiography after 1, 2, 4 and 12 weeks posttransplantation. RESULTS: Complete healing was achieved in all defects although defects with PEG hydrogel presented better bone formation while STRO-1+ and unsorted TGSCs showed similar ability to form new bone after 12 weeks. Transplanted cells were seen in defects where PEG hydrogel was used as carriers in contrast to defects treated with cells and only bone grafts. CONCLUSIONS: PEG hydrogel is an efficient carrier for homologous stem cell transplantation. TGSCs are capable of promoting bone healing in critical-sized defects in combination with bone graft and PEG hydrogel. CLINICAL RELEVANCE: This study provides information about the importance of the delivery vehicle for future translational stem cell delivery approaches.


Assuntos
Hidroxiapatitas , Osteogênese , Animais , Regeneração Óssea , Diferenciação Celular , Células-Tronco , Suínos , Germe de Dente
2.
J Biomed Mater Res B Appl Biomater ; 104(3): 546-53, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25952407

RESUMO

Resorbable bone substitute materials are widely used for bone augmentation after tumor resection, parallel to implant placement, or in critical size bone defects. In this study, the structural dissolution of a biphasic calcium phosphate bone substitute material with a hydroxyapatite (HA)/tricalcium phosphate (ß-TCP) ratio of 60/40 was investigated by repeatedly placing porous blocks in EDTA solution at 37 °C. At several time points, the blocks were investigated by SEM, µCT, and gravimetry. It was found that always complete 2-3 µm sized grains were removed from the structure and that the ß-TCP is dissolved more rapidly. This selective dissolution of the ß-TCP grains was confirmed by XRD measurements. The blocks were eroded from the outside toward the center. The structure remained mechanically stable because the central part showed a delayed degradation and because the slower dissolving HA grains preserved the integrity of the structure.


Assuntos
Fosfatos de Cálcio/química , Cerâmica/química , Durapatita/química , Microscopia Eletrônica de Varredura , Difração de Raios X , Microtomografia por Raio-X
3.
J Clin Periodontol ; 41(8): 820-6, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24738890

RESUMO

AIM: To test the hypothesis that a synthetic hydroxyapatite/ß-tricalcium phosphate (HA/TCP) construct combined with polyethylene glycol (PEG) hydrogel including recombinant human bone morphogenetic proteins-2 (rhBMP-2) enhances new bone formation compared with bone morphogenetic proteins-2 (BMP-2) delivered using the HA/TCP construct alone. MATERIAL AND METHODS: Bilateral mandibular partial thickness 20 × 8 × 8 mm (L × W × H) alveolar defects were surgically created in the edentulated posterior mandible in 18 female minipigs. Randomized into two groups of nine animals each, the alveolar defects either received HA/TCP or HA/TCP/PEG with or without BMP-2 (105 µg/defect) in contra-lateral sites using a split-mouth design. Primary outcome, bone density (%) within four regions of interest, was evaluated following a 4-week healing interval when the animals were killed for histometric analysis. RESULTS: Bone morphogenetic proteins-2 loaded onto HA/TCP constructs significantly enhanced new bone formation compared with HA/TCP controls. Adding PEG apparently obstructed BMP-2 induced bone formation. CONCLUSION: Polyethylene glycol compromises the osteogenic effect of BMP-2.


Assuntos
Proteína Morfogenética Óssea 2/uso terapêutico , Substitutos Ósseos/uso terapêutico , Fosfatos de Cálcio/uso terapêutico , Hidrogel de Polietilenoglicol-Dimetacrilato/uso terapêutico , Doenças Mandibulares/cirurgia , Reconstrução Mandibular/métodos , Fator de Crescimento Transformador beta/uso terapêutico , Perda do Osso Alveolar/cirurgia , Processo Alveolar/efeitos dos fármacos , Processo Alveolar/patologia , Animais , Materiais Biocompatíveis/uso terapêutico , Densidade Óssea/efeitos dos fármacos , Portadores de Fármacos , Feminino , Arcada Parcialmente Edêntula/cirurgia , Mandíbula/efeitos dos fármacos , Mandíbula/patologia , Osteogênese/efeitos dos fármacos , Distribuição Aleatória , Proteínas Recombinantes/uso terapêutico , Suínos , Porco Miniatura
4.
Clin Oral Implants Res ; 25(1): 16-20, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23173910

RESUMO

OBJECTIVES: To evaluate the early cellular attachment and viability to modified polyethylene glycol (PEG) hydrogels with the influence of arginine-glycine-aspartic acid (RGD) in an in vitro model system. MATERIAL AND METHODS: Human gingival fibroblasts (HGF-1) were cultured on 6 different modalities of PEG hydrogel in hydrophobic polystyrene wells. A total of 7500 cells/well (10,000 cells/cm(2)) were dispersed over the PEG filled wells and incubated in triplicates for 24 h, 7 and 13 days. Cell numbers were calculated by means of a NucleoCounter. Cell viability was determined by measuring lactate dehydrogenase (LDH). For statistical analysis, nonparametric Kruska-Wallis test followed by Dunetts T3 test were used. RESULTS: All PEG modifications showed good biocompatibility, as demonstrated by low LDH values per cell at the earlier two time points. After 13 days, all PEG modifications showed significantly lower number of cells compared with the controls, and the MX60 configurations demonstrated significantly higher LDH/cell values compared with the other hydrogels. CONCLUSIONS: Modifications of the physio-chemical properties of PEG hydrogels and the addition of RGD and spacers influenced the initial cellular response of cultured HGF-1 cells. With the exception of MX60 after 13 days, all PEG formulations performed similarly well. Early cellular response should be considered when developing PEG-based material for clinical purposes.


Assuntos
Materiais Biocompatíveis/farmacologia , Regeneração Óssea , Fibroblastos/fisiologia , Gengiva/citologia , Regeneração Tecidual Guiada/métodos , Hidrogéis/farmacologia , Polietilenoglicóis/farmacologia , Técnicas de Cultura de Células , Sobrevivência Celular , Células Cultivadas , Humanos , Técnicas In Vitro , Membranas Artificiais , Oligopeptídeos/farmacologia
5.
Clin Oral Implants Res ; 24(8): 910-20, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23865504

RESUMO

OBJECTIVE: The objective of this study was to investigate if osseous regeneration can be accelerated by involvement of periosteal tissue. Bone defect regeneration could be accelerated by the involvement of periosteal tissue if osteogenic cell signalling is maintained within the defect. It was questioned if local cell-mediated BMP-2 gene delivery makes a cell occlusive membrane dispensable during bone critical size defect regeneration. METHODS: PEG matrix (degradation time 10 days) and PEG membrane (degradation time 120 days) were used in the pig calvarial model. Cylindrical (1 × 1 cm) critical size defects (CSD) (9 per animal; 20 animals) were filled with: (i) particulated autologous bone, covered with PEG membrane (group 1); (ii) HA/TCP, covered with PEG membrane (group 2); (iii) HA/TCP, mixed with PEG matrix (group 3); and (iv) HA/TCP mixed with BMP-2-transfected osteoblasts and PEG matrix (group 4). BMP-2/4 gene transfer: liposomal in vitro transfection of BMP-2/V5-tag fusion-protein. Quantitative histomorphometry (toluidine blue staining) after 2, 4 and 12 weeks assessed bone formation. Semiquantitative immunohistochemistry estimated the expression of BMP-2, V5-tag, Runx-2 and Sox9. RESULTS: PEG matrix embedded BMP-2 expressing cells presented higher bone formation (P < 0.05) than HA/TCP + PEG matrix defect filling or PEG membrane covering (HA/TCP filling) after 12 weeks. Highest expression of BMP-2, Runx-2 and lowest expression of fibrous tissue marker Sox9 was seen in the BMP-2 group. CONCLUSION: PEG matrix embedded BMP-2 expressing cells are capable to maintain osteogenic signalling and to accelerate osseous defect regeneration in absence of a cell occlusive membrane.


Assuntos
Doenças Ósseas/cirurgia , Proteína Morfogenética Óssea 2/uso terapêutico , Regeneração Óssea/fisiologia , Hidrogel de Polietilenoglicol-Dimetacrilato/química , Membranas Artificiais , Osteogênese/fisiologia , Crânio/cirurgia , Alicerces Teciduais/química , Implantes Absorvíveis , Animais , Autoenxertos/transplante , Proteína Morfogenética Óssea 2/genética , Substitutos Ósseos/uso terapêutico , Transplante Ósseo/métodos , Linhagem Celular , Subunidade alfa 1 de Fator de Ligação ao Core/análise , Modelos Animais de Doenças , Técnicas de Transferência de Genes , Regeneração Tecidual Guiada/métodos , Humanos , Hidroxiapatitas/uso terapêutico , Osteoblastos/fisiologia , Periósteo/fisiologia , Distribuição Aleatória , Proteínas Recombinantes de Fusão/análise , Fatores de Transcrição SOX9/análise , Suínos , Fatores de Tempo , Transfecção/métodos
6.
Biomaterials ; 31(3): 449-60, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19819013

RESUMO

Modifications of implant surface topography and chemistry have proven a means to enhance osseointegration, a process that ensures the stability of bone-contacting devices, including titanium dental implants. The commercial product Emdogain is an enamel matrix derivative (EMD) extracted from porcine teeth commonly used in periodontal surgery, where it has been shown to potentiate regeneration of bone. The aim of the present study was to evaluate the effect of EMD on the attachment, proliferation and differentiation of osteoblasts on titanium surfaces in vitro. Pickled (smooth) and SLA (roughened) titanium discs were coated with EMD or left uncoated. Primary rat calvarial osteoblasts were cultured on each surface from 1h to 4 weeks. EMD significantly increased cell spreading and proliferation at time points ranging from 3 to 7 days on both topographies. Alkaline phosphatase activity was significantly increased on EMD-coated titanium compared with titanium alone. Moreover, there was a 6 fold increase in levels of mRNA encoding bone sialoprotein and osteocalcin in osteoblasts cultured on EMD-coated titanium surfaces compared with uncoated surfaces. We conclude that coating of titanium with EMD enhances the proliferation and differentiation of osteoblasts irrespective of the titanium substratum topography.


Assuntos
Diferenciação Celular/fisiologia , Proliferação de Células , Materiais Revestidos Biocompatíveis/metabolismo , Proteínas do Esmalte Dentário/metabolismo , Osteoblastos/fisiologia , Titânio/química , Animais , Biomarcadores/metabolismo , Células Cultivadas , Materiais Revestidos Biocompatíveis/química , Subunidade alfa 1 de Fator de Ligação ao Core/genética , Subunidade alfa 1 de Fator de Ligação ao Core/metabolismo , Proteínas do Esmalte Dentário/genética , Sialoproteína de Ligação à Integrina , Teste de Materiais , Osteoblastos/citologia , Osteocalcina/genética , Osteocalcina/metabolismo , Ratos , Sialoglicoproteínas/genética , Sialoglicoproteínas/metabolismo , Propriedades de Superfície , Titânio/metabolismo
7.
J Biomed Mater Res A ; 85(2): 285-92, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-17688293

RESUMO

The use of guided bone regeneration (GBR) techniques requires new materials meeting the needs of clinical application. Design criteria for GBR devices are biocompatibility, tissue occlusion, space provision, and clinical manageability. This study evaluates a novel biodegradable poly (ethylene glycol) (PEG) based material as tissue occlusive membrane. A subcutaneous implant model in rats was developed to test the barrier function of the PEG hydrogels over time. Fourteen rats received three membrane implants and two positive controls each. Explants were collected over a period of 7 months. Histological analysis revealed that for at least 4 months cellular infiltration in the membrane explants was lower than 1% of that of the positive controls. Therefore, the PEG based hydrogel can be regarded as tissue occlusive during this period of time. A barrier function seems to be maintained for up to 6 months. In vitro degradation studies performed with the same PEG constructs confirm the in vivo result. In conclusion, our results indicate that this novel PEG-based material has potential for use as a GBR barrier membrane.


Assuntos
Regeneração Óssea , Regeneração Tecidual Guiada , Hidrogéis , Teste de Materiais , Membranas Artificiais , Polietilenoglicóis , Animais , Feminino , Regeneração Tecidual Guiada/métodos , Teste de Materiais/métodos , Ratos , Ratos Sprague-Dawley , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA